Tuesday, October 27, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Eli Lilly, Novo Nordisk Antitrust Suit Remains Dismissed

MH

By Maren Holt · Senior Reporter, GLP-1

Oct 23 22:14 ETSource: Law360

From the source

Eli Lilly, Novo Nordisk Antitrust Suit Remains Dismissed

Read at law360.com

Source URL https://www.law360.com/healthcare-authority/articles/2542047/eli-lilly-novo-nordisk-antitrust-suit-remains-dismissed

Prescribed peptides from $99/moSee all →